PROJECTS INTRODUTION

    Investment required: £5m

 

    Clinical/Healthcare: Foetal and Maternal Monitoring

 

    Synopsis
    an innovative, wearable device that accurately monitors FHR, MHR, UA and maternal activity, offering an alternative wireless ambulatory monitoring solution for induction, obesity, L&D and patient satisfaction. The Monica AN24 is available:
    • In Europe (CE) and the US (FDA) as solution for maternal‐fetal monitoring during labour & delivery
    • As part of a homecare/mhealth solution
    • For research

 

    Stage ‐ Pipeline Expansion
    The new Monica IF24 CTG Interface Device accessory allows Monica's unique AN24 fetal/maternal monitoring technology to work with your installed CTG monitor, making the benefits of both available to you: peace of mind from Monica's improved accuracy and the patient comfort of a beltless and ambulatory monitoring solution, alongside the familiarity of using your own CTG monitor. It also provides docking station for charging and storing the AN24 when not in use.

Helosina
Company:
Helosina is Vitwo.cn’s subordinate service platform helping foreign property owners find Chinese investors. Due to the transformation and upgrading of Chinese economy, there is storming demand for hi...more
Contact:

Contact:Nicholas Zhou

Email:nicholas@helosina.com

Tel:86 591 87678231

Fax:

Website:www.helosina.com

Address:Room 603, Building A, Tianyuangang Center, C2, East 3rd Ring North Road, Chaoyang District, Beijing,100020,CHINA

PROJECTS PICTURES
OTHER PROJECTS
    No Products